Annual And Sustainability Report

Overview

The report describes BioArctic's record 2025 net revenue of SEK 1,999.1 M and continued expansion of Leqembi, including its launch in Europe and approvals in more than 50 markets. It also highlights a new BrainTransporter collaboration with Novartis, alongside existing partnerships with Eisai and Bristol Myers Squibb. Sustainability disclosures include a double materiality assessment, 100 percent renewable energy consumption, and a 65% value-chain CO2 reduction target for 2035.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Publication date: 21 April 2026
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services